Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

184

...

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
V07AB01	WATER FOR INJECTION/ DEMO	G	Water for injection -		Water for injection, irrigation	1,339,811 L.L
V07AB01	WATER FOR INJECTION/ DEMO	G	Water for injection -		Water for injection, irrigation	1,103,295 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	128,412,818 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	295,369,569 L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	52,788,606 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	275,097,581 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	613,462,617 L.L
B01AC27	UPTRAVI	B	Selexipag - 400mcg	400mcg	Tablet, film coated	275,097,581 L.L
B01AC27	UPTRAVI	B	Selexipag - 600mcg	600mcg	Tablet, film coated	275,097,581 L.L
B01AC27	UPTRAVI	B	Selexipag - 800mcg	800mcg	Tablet, film coated	275,097,581 L.L
B01AC27	UPTRAVI	B	Selexipag - 1000mcg	1000mcg	Tablet, film coated	275,097,581 L.L
B01AC27	UPTRAVI	B	Selexipag - 1200mcg	1200mcg	Tablet, film coated	275,097,581 L.L
B01AC27	UPTRAVI	B	Selexipag - 1400mcg	1400mcg	Tablet, film coated	275,097,581 L.L
B01AC27	UPTRAVI	B	Selexipag - 1600mcg	1600mcg	Tablet, film coated	275,097,581 L.L
B01AD02	ACTILYSE	BioTech	Alteplase - 50mg	50mg	Injectable dry powder for solution+diluent	94,282,861 L.L
B01AD11	METALYSE	BioTech	Tenecteplase - 10,000IU	10,000IU	Injectable powder for solution+diluent	72,657,303 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	38,763,115 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 2g	2g	Injectable powder for solution	77,527,404 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	38,762,207 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	37,797,298 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	74,575,183 L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	102,980,708 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	56,263,955 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 5mg	5mg (250KIU)	Injectable powder for solution+diluent	257,452,982 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	47,533,131 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	67,369,332 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	78,295,560 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	143,306,217 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	352,833,901 L.L

...

184

...